Health and Fitness

FDA Approves First Generic Copaxone to Treat Multiple Sclerosis

Silver Spring, Maryland–(ENEWSPF)–April 16, 2015. The U.S. Food and Drug Administration today approved the first generic version of Copaxone (glatiramer acetate injection), used to treat patients with relapsing forms of multiple sclerosis (MS). Sandoz has received FDA approval to market generic glatiramer acetate in a 20 mg/1 ml daily injection.[Read More…]

Groups Deliver 220K Petition Signatures Urging Senate to Reject Abortion Restrictions in Human Trafficking Bill

WASHINGTON, DC —(ENEWSPF)–April 16, 2015.  More than 220,000 petition signatures have been delivered to members of Congress, urging them to reject the most recent attacks on safe, legal abortion being pushed forward by Senator John Cornyn and his allies as part of an otherwise bipartisan effort to support survivors of[Read More…]

Jackson Park Hospital RNs Send Years’ Worth of Unsafe Staffing Complaints to Regulatory Agencies

Administration’s lack of response could impact hospital licensure. CHICAGO–(ENEWSPF)–April 16, 2015.  The registered nurses of Jackson Park Hospital and Medical Center (JPH), on Chicago’s South Side, are taking a stand for their patients on Thursday, at a press conference announcing that years’ worth of forms documenting unsafe staffing and dangerous[Read More…]

NIH Study Finds Genetic Link for Rare Intestinal Cancer

Researchers recommend screening for people with family history Bethesda, Maryland–(ENEWSPF)–April 16, 2015.  Heredity accounts for up to 35 percent of small intestinal carcinoid, a rare digestive cancer, according to findings from a team at the National Institutes of Health. The researchers examined families with a history of the disease. Because[Read More…]

NIH Launches Largest Clinical Trial Focused on HIV-related Cardiovascular Disease

Bethesda, Maryland–(ENEWSPF)–April 16, 2015.  Researchers have begun enrolling participants in a multicenter international clinical trial to test whether statin administration can reduce the risk for major adverse cardiovascular events, such as heart attacks, strokes, and heart disease, in people with HIV infection. The trial is supported by the National Institutes[Read More…]

FDA Approves Corlanor to Treat Heart Failure

Silver Spring, Maryland–(ENEWSPF)–April 15, 2015.  The U.S. Food and Drug Administration today approved Corlanor (ivabradine) to reduce hospitalization from worsening heart failure. Corlanor is approved for use in certain people who have long-lasting (chronic) heart failure caused by the lower-left part of their heart not contracting well. The drug is[Read More…]

Bipartisan Coalition Introduce Bill to Support 9/11 First Responders with Vital Health Programs

Bill Would Reauthorize Health Programs for 9/11 Responders and Survivors; 170 Illinoisans Currently Enrolled in World Trade Center Health Program WASHINGTON –-(ENEWSPF)–April 14, 2015.  U.S. Senator Mark Kirk (R-Ill.) today, along with U.S. Senators Kirsten Gillibrand (D-N.Y.), Chuck Schumer (D-N.Y.) and Lisa Murkowski (R-Alaska), introduced the James Zadroga 9/11 Health[Read More…]

HHS to Probe Skyrocketing Generic Drug Prices

WASHINGTON–(ENEWSPF)–April 14, 2015 – At the urging of Sen. Bernie Sanders (I-Vt.) and Rep. Elijah Cummings (D-Md.), the Department of Health and Human Services inspector general has agreed to investigate how sudden price hikes by generic drug makers are driving up the cost of taxpayer-supported health care. “It is unacceptable[Read More…]

Most read stories this week

Take a Survey

ARCHIVES